𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Idiopathic myelofibrosis terminating in erythroleukemia

✍ Scribed by Dr. Sonia Garcia; Amparo Miguel; Alicia Miguel; Mariano Linares; Miguel Navarro; Pedro Colomina


Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
166 KB
Volume
32
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

✦ Synopsis


A 55-year-old woman with a one-year history of idiopathic myelofibrosis progressed to erythroleukemia. This is the first reported occurrence of erythroleukemia progression from idiopathic myelofibrosis. Certain patterns of leukemia transformation from myeloproliferative disorders are favored: Myeloblastic or rnyelomonocytic. The rare incidence of erythroblastic transformation is discussed.


πŸ“œ SIMILAR VOLUMES


Sideroblastic anemia terminating in myel
✍ Dr. Daniel F. Lukowicz; Thomas J. Myers; Joseph A. Grasso; Maurice M. Albala πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 753 KB

## Abstract Two patients with primary acquired sideroblastic anemia who eventually developed myelofibrosis with myeloid metaplasia are reported. Splenectomy was performed in one patient because of increasing blood transfusion requirements, and splenic histology revealed both myeloid metaplasia and

Idiotype in myeloma terminating in eryth
✍ Barcos, Maurice ;Kim, Seung ;Seon, Ben K. ;Nussbaum, Annie ;Gailani, Salman ;Hen πŸ“‚ Article πŸ“… 1979 πŸ› John Wiley and Sons 🌐 English βš– 613 KB

A patient with multiple myeloma, IgG kappa type, developed erythroleukemia with cytogenetic abnormalities three years after diagnosis. The latter disease progressed terminally to acute granulocytic leukemia. Anti-idiotype antibody reagents were prepared by injecting rabbits with the purified monoclo

Idiopathic acquired sideroblastic anemia
✍ Dr. Kai-Yiu Yeung; Arthur A. Trowbridge πŸ“‚ Article πŸ“… 1977 πŸ› John Wiley and Sons 🌐 English βš– 585 KB

Acute myelofibrosis is a rare but distinct accelerated variant of agnogenic myeloid metaplasia that is characterized by marked anemia, peripheral blood myeloblastosis and normoblastosis, a lack of teardrop poikilocytosis, and prominent myelofibrosis. There is usually no palpable hepatosplenomegaly o